Skip to main content

Correction to: Respiratory support in COPD patients after acute exacerbation with monitoring the quality of support (Rescue2-monitor): an open-label, prospective randomized, controlled, superiority clinical trial comparing hospital- versus home-based acute non-invasive ventilation for patients with hypercapnic chronic obstructive pulmonary disease

Correction to: Trials 21, 877 (2020)

https://doi.org/10.1186/s13063-020-04672-w

After publication of the original article [1], it came to the authors’ attention that one sponsor declaration was missing in the funding section.

The funding section of the original article has been updated as follows in order to include L3medical as additional sponsor.

Funding: Monetary support for sponsoring the study will be provided by La Fondation du Souffle (ex. BREAS), Sociedad espanola de neumologia y de cirurgia toracica (SEPAR), the Société de pneumologie de langue française (SPLF), L3medical, and Air Liquide Healthcare. La Fondation du Souffle, as sponsor, is involved in the data collection and has ownership of the data. However, it has no involvement in design of the study, analysis, and interpretation of the data and in writing the protocol/manuscript. The SEPAR and SPLF were involved in the design of the study and will be involved in data analysis and interpretation as well as the writing of protocol/manuscripts. Air Liquide Healthcare is not involved in any of the following aspects: study design; collection, management, analysis, and interpretation of data; writing of the protocol or manuscript.

This change does not affect the scientific content of the paper.

The original article has been corrected.

Reference

  1. 1.

    On behalf of the Rescue2-monitor group. Respiratory support in COPD patients after acute exacerbation with monitoring the quality of support (Rescue2-monitor): an open-label, prospective randomized, controlled, superiority clinical trial comparing hospital- versus home-based acute non-invasive ventilation for patients with hypercapnic chronic obstructive pulmonary disease. Trials. 2020;21:877. https://doi.org/10.1186/s13063-020-04672-w.

    Article  Google Scholar 

Download references

Author information

Affiliations

Consortia

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

On behalf of the Rescue2-monitor group. Correction to: Respiratory support in COPD patients after acute exacerbation with monitoring the quality of support (Rescue2-monitor): an open-label, prospective randomized, controlled, superiority clinical trial comparing hospital- versus home-based acute non-invasive ventilation for patients with hypercapnic chronic obstructive pulmonary disease. Trials 21, 961 (2020). https://doi.org/10.1186/s13063-020-04900-3

Download citation